Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: A case study

Anticancer Research

Volumn 28, Issue 1 B, 2008, Pages 539-541

  Ardavanis, A ^a,b   Kountourakis, P ^a   Orphanos, G ^a   Rigatos, G ^a  

^a 1st Department of Medical Oncology   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Bone marrow infiltration; Capecitabine; Metastatic breast cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CAPECITABINE; EPIRUBICIN; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM STAGING;

EID: 40549143998     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P and Miccoli P: Metastatic breast cancer: an updating. Biomed Pharmacother 60(9): 548-556, 2006.
2. Kamby C, Guldhammer B, Vejborg I, Rossing N, Dirksen H, Dangaard S and Mouridsen HT: The precense of tumor cells in bone marrow at the time of first recurrence in breast cancer. Cancer 60: 1306-1312, 1987.
3. Freyer G, Ligneau B and Trillet-Lenoir V: Palliative hormone therapy, low-dose chemotherapy and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience. Eur J Int Med 11: 329-333, 2000.
4. Gebauer G, Fehm T, Merkle E, Beck EP, Lang N and Jager W: Epithelial cells in bone marrow of breast cancer patients at time of primary surgery:clinical outcome during long-term follow up. J Clin Oncol 19: 3669-3674, 2001.
5. Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Ovist H, Schlichting E, Sauer T, Janbu J, Harbitz T and Naume B: Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21(18): 3469-3478, 2003.
6. Singletary SE, Larry L, Tucker SL and Spitzer G: Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 47: 32-36, 1991.
7. Molino A, Pelosi G, Turazza M, Sperotto L, Bonetti A, Nortilli R, Fattovich G, Alaimo C, Piubello Q, Pavanel F, Micciolo R and Cetto GL: Bone marrow micrometastases in 109 breast cancer patients:correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42: 23-30, 1997.
8. Ingle JN, Tormey DC, Bull JM and Simon RM: Bone marrow involvement in breast cancer:effect on response and tolerance to combination chemotherapy. Cancer 39: 250-257, 1977.
9. Rodriguez-Kraul R, Hortobagyi GN, Buzdar AU and Blumenschein GR: Combination chemotherapy for breast cancer metastatic to bone marrow. Cancer 48(2): 227-232, 1981.
10. Bjelic-Radisic V, Stoger H, Winter R, Beham-Schmid C and Petru E: Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient:a case report. Anticancer Res 26: 1627-1630, 2006.
11. Gelmon K, Chan A and Harbeck N: The role of capecitabine in first-line treatment for patients with metastatic breast cancer. Oncologist 11(Suppl 1): 42-51, 2006.
12. Wardley A: Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer. Oncologist 11(Suppl): 20-26, 2006.
13. Stathopoulos GP, Koutantos J, Lazaki H, Rigatos SK, Stathopoulos J and Delikonstantinos J: Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects. Anticancer Res 27: 1653-1656, 2007.
14. Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M and Bastert G: Reduction in new metastases in breast cancer with adjuvant clodronate treatment. New Engl J Med 339: 357-363, 1998.